Subject(s)

Atrial Fibrillation/therapy , Acute Coronary Syndrome/epidemiology , Acute Coronary Syndrome/therapy , Aged , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Anticoagulants/therapeutic use , Athletes/statistics & numerical data , Atrial Fibrillation/diagnosis , Atrial Fibrillation/epidemiology , Atrial Fibrillation/etiology , Atrial Fibrillation/physiopathology , Cardiomyopathy, Hypertrophic/epidemiology , Comorbidity , Diabetes Mellitus/epidemiology , Electric Countershock/instrumentation , Electric Countershock/methods , Female , Fibrinolytic Agents/therapeutic use , Heart Failure/drug therapy , Heart Failure/epidemiology , Heart Rate/drug effects , Heart Rate/physiology , Heart Valve Diseases/epidemiology , Heart Valve Diseases/therapy , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Hyperthyroidism/epidemiology , Lung Diseases/epidemiology , Male , Middle Aged , Mineralocorticoid Receptor Antagonists/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Pregnancy , Prevalence , Wolff-Parkinson-White Syndrome/epidemiology

Subject(s)

Atrial Fibrillation , Acute Coronary Syndrome/complications , Acute Coronary Syndrome/therapy , Adult , Aged , Angioplasty, Balloon, Coronary/methods , Anti-Arrhythmia Agents/therapeutic use , Atrial Fibrillation/diagnosis , Atrial Fibrillation/etiology , Atrial Fibrillation/therapy , Catheter Ablation/methods , Electric Countershock/methods , Electrocardiography , Fibrinolytic Agents/therapeutic use , Heart Failure/etiology , Heart Valve Diseases/complications , Hemorrhage/chemically induced , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , International Normalized Ratio , Intraoperative Care , Middle Aged , Mineralocorticoid Receptor Antagonists/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Point-of-Care Systems , Postoperative Complications/etiology , Postoperative Complications/therapy , Precision Medicine , Primary Prevention , Quality of Life , Recurrence , Risk Assessment , Secondary Prevention , Sports , Stroke/prevention & control , Thromboembolism/etiology , Ventricular Dysfunction, Left/etiology